ArticleBMC gastroenterology2025
Application of laparoscopic liver surgery techniques in laparoscopic thermal ablation of liver tumors.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe utility of laparoscopic thermal ablation (LTA) for liver tumors is restricted when lesions are unfavorably located. To address this challenge, our study investigated the feasibility and safety of enhancing LTA with laparoscopic liver surgery techniques (LLSTs).
methodsClinical data of patients who underwent LTA with LLSTs at the Second Affiliated Hospital, Third Military Medical University (Army Medical University) from April 2020 to December 2023 were retrospectively analyzed.
resultsA total of 61 lesions in 28 patients (mean age: 56.50 ± 9.65 years) with multifocal liver tumors were included. The technical success rate was 100%, with an average ablation duration of 22.32 ± 12.53 min (10.25 ± 1.29 min per lesion). Average blood loss was 85.71 ± 40.50 ml, and the average hospital stay was 4.43 ± 1.50 days. No major postoperative complications were observed, and patients with minor complications recovered after conservative treatment. During follow-up, one lesion developed local recurrence, resulting in a local control rate of 95.08%.
conclusionsFor challenging liver tumor cases, LTA guided by LLST is an effective method. However, its limitations must be addressed through continued development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.